NIH Renews Funding for the Antibacterial Resistance Leadership Group | NIH: National Institute of Allergy and Infectious Diseases

NIH Renews Funding for the Antibacterial Resistance Leadership Group | NIH: National Institute of Allergy and Infectious Diseases

Friday, December 13, 2019 NIH Renews Funding for the Antibacterial Resistance Leadership Group As antibiotic-resistant bacteria become more urgent threats worldwide, NIAID is pleased to announce its ongoing support for the Antibacterial Resistance Leadership Group (ARLG), a global consortium of scientific experts who oversee important clinical research on antibacterial resistance. This renewed funding will allow the ARLG to conduct and support critical research for an additional seven years.